Mutual of America Capital Management’s Esperion Therapeutics ESPR Stock Holding History

Mutual of America Capital Management’s Portfolio ESPR Stock Details ESPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-73,662	Closed	-$1.56M	–	1655
2021 Q2	$1.56M	Sell	73,662 -3,169	-4%	-$76.3K	0.02%	1036
2021 Q1	$2.15M	Sell	76,831 -4,252	-5%	-$125K	0.02%	934
2020 Q4	$2.11M	Sell	81,083 -1,707	-2%	-$51.1K	0.02%	881
2020 Q3	$3.08M	Buy	82,790 +26,640	+47%	+$1.06M	0.04%	610
2020 Q2	$2.88M	Buy	56,150 +23,930	+74%	+$1M	0.04%	631
2020 Q1	$1.02M	Buy	+32,220	New	+$1.7M	0.02%	977
2015 Q3	–	Sell	-20,317	Closed	-$1.66M	–	1258
2015 Q2	$1.66M	Hold	20,317	–	–	0.04%	799
2015 Q1	$1.88M	Buy	+20,317	New	+$1.31M	0.04%	745

Other funds holding ESPR

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

RPAM

Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Mutual of America Capital Management's ESPR Position: Q3 2021 in Review

Mutual of America Capital Management sold out of Esperion Therapeutics (ESPR) in Q3 2021, closing a stake of 73,662 shares — an estimated $1.56M sold.

Mutual of America Capital Management first reported a position in ESPR in Q1 2015 and held it in 8 quarters. The position peaked at $3.08M in Q3 2020. 139 funds tracked by Wall St. Rank hold ESPR as of Q3 2021.

Mutual of America Capital Management reported no remaining Esperion Therapeutics position as of Q3 2021 after selling out during the quarter.
Mutual of America Capital Management sold 73,662 Esperion Therapeutics shares in Q3 2021, an estimated $1.56M.
Mutual of America Capital Management first reported a position in Esperion Therapeutics in Q1 2015 and held it in 8 quarters.
Mutual of America Capital Management's Esperion Therapeutics position peaked at $3.08M in Q3 2020.
139 funds tracked by Wall St. Rank held Esperion Therapeutics as of Q3 2021.

Based on Mutual of America Capital Management's 13F filing for Q3 2021, filed 10 Nov 2021.